Eric E. Poma - Aug 25, 2025 Form 4 Insider Report for Calidi Biotherapeutics, Inc. (CLDI)

Role
Chief Executive Officer, Director
Signature
/s/ Andrew Jackson, Attorney-in-fact
Stock symbol
CLDI
Transactions as of
Aug 25, 2025
Transactions value $
$50,000
Form type
4
Date filed
8/25/2025, 08:47 PM
Previous filing
Apr 25, 2025
Next filing
Sep 5, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Poma Eric E Chief Executive Officer, Director C/O CALIDI BIOTHERAPEUTICS, INC., 4475 EXECUTIVE DRIVE, SUITE 200, SAN DIEGO, /s/ Andrew Jackson, Attorney-in-fact 2025-08-25 0001339484

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLDI Common Stock Purchase $50K +25K $2.00 25K Aug 21, 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLDI Warrant (right to buy) Purchase +25K 25K Aug 21, 2025 Common stock 25K $2.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The common stock and warrants were acquired by the reporting person in a public offering conducted by the Issuer that was closed on August 21, 2025.
F2 Each common share was purchased with an accompanying warrant for a purchase price of $2.00 per share and accompanying warrant.

Remarks:

Exhibit 24 - Power of Attorney